
    
      Aim 1: Evaluate the effects of probiotic supplements on improvement in MELD score and gut
      mucosal integrity in patients with MELD < 21. Patients will be randomized to receive daily
      probiotics for 6 months and standard of care treatment or placebo with standard care.

      Aim 2: Document the natural history of moderately severe alcoholic hepatitis. Patients who
      decline randomization will be offered the option of inclusion in the study prospectively for
      data collection purposes and research study procedures.

      Aim 3: Create a data and tissue biorepository. This biorepository will serve as a national
      resource for studies related to acute alcoholic hepatitis.
    
  